ASCENT Intervention for Brain Tumor Patients

Launched by MASSACHUSETTS GENERAL HOSPITAL · Oct 19, 2023

Keywords

ClinConnect Summary

The ASCENT trial is a study designed to help patients diagnosed with malignant brain tumors, specifically focusing on how to improve their emotional well-being and coping skills. Researchers want to see if a new support program, called ASCENT, is practical and helpful for patients. If you are eligible, you’ll be asked to take part in six coaching sessions and fill out short surveys to share your experience. Some participants may also be invited to provide feedback through interviews to help improve the program.

To be eligible for this trial, you need to be at least 18 years old, have been diagnosed with a malignant brain tumor within the last six months, and be a patient at Massachusetts General Hospital Cancer Center. You should also be able to speak English. It’s important to note that people with certain severe cognitive issues or those currently in hospice care won't be able to participate. This trial is not yet recruiting participants, but it aims to provide valuable support to those facing the challenges of a brain tumor diagnosis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18
• • Massachusetts General Hospital Cancer Center Patient
• • Within 6 months of diagnosis of malignant primary Central Nervous System (CNS) tumor
• • English speaking
• Exclusion Criteria:
• • Inability to provide informed consent as assessed by the study team (e.g., due to severe cognitive impairment/dementia)
• • Moderate to severe receptive aphasia (Quick Aphasia Battery sentence comprehension subscale \< 8)
• • Current or imminent hospice enrollment